Press release
Immuno-Oncology Drugs Market 2022-31 : Industry Analysis, Size, Share, Growth and Forecast | Amgen Inc., AstraZeneca Plc, Bristol-Myers Squibb, Celgene Corporation, Eli Lilly and Company
The global immuno-oncology drugs market size is expected to grow from $60.32 billion in 2021 to $70.59 billion in 2022 at a compound annual growth rate (CAGR) of 17.0%. The growth in the market is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The immuno-oncology market is expected to reach $120.37 billion in 2026 at a CAGR of 14.3%.The Business Research Company offers the Immuno-Oncology Drugs Global Market Report 2022 in its research report store. It is the most comprehensive report available on this market and will help gain a truly global perspective as it covers 60 geographies. The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by region and by country. It also compares the market's historic and forecast growth, and highlights important trends and strategies that players in the market can adopt.
Directly purchase the report here: https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3455
The immuno-oncology drugs market consists of sales of immuno-oncology drugs used for the treatment of cancer and related services by entities (organizations, sole traders and partnerships) that produce immuno-oncology drugs for cancer treatment. Immuno-oncology is the artificial stimulation of the immune system to treat cancer, improving the immune system's ability to fight the disease. The market consists of revenue generated by the companies manufacturing immuno-oncology drugs by the sales of these products.
Some key immuno-oncology drugs market are Amgen Inc., AstraZeneca Plc, Bristol-Myers Squibb, Celgene Corporation, Eli Lilly and Company, Merck & Co., F. Hoffmann-La Roche AG, Johnson & Johnson, Novartis International AG and AbbVie Inc.
The countries covered in the global immuno-oncology drugs market are Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Colombia, Czech Republic, Denmark, Egypt, Finland, France, Germany, Hong Kong, India, Indonesia, Ireland, Israel, Italy, Japan, Malaysia, Mexico, Netherlands, New Zealand, Nigeria, Norway, Peru, Philippines, Poland, Portugal, Romania, Russia, Saudi Arabia, Singapore, South Africa, South Korea, Spain, Sweden, Switzerland, Thailand, Turkey, UAE, UK, USA, Venezuela, Vietnam.
The regions covered in the global immuno-oncology drugs market are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Immuno-Oncology Drugs Market Segmentation:
1) By Type
Monoclonal Antibodies
Immune Checkpoint Inhibitors
Immune System Modulators
Cancer Vaccines
2) By Therapeutic Application
Melanoma
Lung Cancer
Blood Cancer
Renal Cell Carcinoma
Prostate Cancer
Bladder Cancer
3) By End-User
Hospitals
Clinics
Ambulatory Surgical Centers
Cancer Research Institutes
See more on the report at https://www.thebusinessresearchcompany.com/report/immuno-oncology-drug-global-market-report
The Report's Table Of Contents includes
1. Executive Summary
2. Immuno-Oncology Drugs Market Characteristics
3. Immuno-Oncology Drugs Market Trends And Strategies
4. Impact Of COVID-19 On Immuno-Oncology Drugs
5. Immuno-Oncology Drugs Market Size And Growth
……
28. Immuno-Oncology Drugs Pipeline Analysis
29. Key Mergers And Acquisitions In The Immuno-Oncology Drugs Market
30. Immuno-Oncology Drugs Market Future Outlook and Potential Analysis
31. Appendix
This report covers the trends and market dynamics of the immuno-oncology drugs market in major countries - Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA. The report also includes consumer surveys and various future opportunities for the market.
Request for a Sample of this report: https://www.thebusinessresearchcompany.com/sample.aspx?id=3455&type=smp
Contact Information:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
Check out our blog: http://blog.tbrc.info/
And follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
About Us:
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that excels in company, market, and consumer research. It has published over 3000 industry reports, covering over 2500 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Immuno-Oncology Drugs Market 2022-31 : Industry Analysis, Size, Share, Growth and Forecast | Amgen Inc., AstraZeneca Plc, Bristol-Myers Squibb, Celgene Corporation, Eli Lilly and Company here
News-ID: 2655303 • Views: …
More Releases from The Business research company
Emerging Sub-Segments Transforming the Organic Soft Drinks Market Landscape
The organic soft drinks sector is gaining momentum as consumers increasingly seek healthier and more environmentally friendly beverage options. With innovation and sustainability becoming key priorities, this market is set to experience steady expansion over the coming years. Let's explore the market size, leading players, prevailing trends, and segmentation details shaping the organic soft drinks landscape.
Projected Expansion of the Organic Soft Drinks Market by 2030
The organic soft drinks…
Leading Companies Enhancing Their Presence in the Super Grid Market
The super grid industry is set for remarkable advancement as global energy demands evolve and sustainability goals become more urgent. As countries prioritize cleaner energy and enhanced power infrastructure, the super grid market is emerging as a critical enabler for efficient, large-scale electricity transmission across regions. Let's explore the market's anticipated growth, key players, latest trends, and segmentation insights shaping its future.
Projected Growth Trajectory of the Super Grid Market …
Top Companies and Competitive Dynamics in the Organic Food Market
The organic food sector is on the verge of remarkable growth, driven by shifting consumer preferences and advancements in sustainable agricultural practices. As more people seek healthier and environmentally friendly options, the market for organic products is expanding rapidly. Let's explore the projected market size, key players, significant trends, and major segments shaping the future of the organic food industry.
Projected Expansion of the Organic Food Market Size Through 2030 …
Global Trends Overview: The Rapid Evolution of the Spectrum Heatmap Analytics Ma …
The spectrum heatmap analytics market is set to experience significant expansion in the coming years, driven by rapid advances in wireless technology and increasing demand for real-time spectrum management solutions. Understanding the market's future valuation, leading players, emerging trends, and segmentation provides valuable insight into this dynamic and evolving industry.
Forecasted Market Size and Growth Trajectory for Spectrum Heatmap Analytics
The market for spectrum heatmap analytics is anticipated to grow…
More Releases for Drugs
Generic Drugs Market Application Anti-Infective Drugs, Anti-Arthritis Drugs, Ant …
Generic drugs are the medications that are developed to be similar to a medicine that is already commercially available in the market with a brand name. The generic drug is similar to the medicine available in terms of dosage, safety and strength, mode of administration, quality and intended use. Due to the similarities, generic drugs are capable of treating various diseases. Generic drugs are most cost effective than the branded…
Cytotoxic Drugs Market Growing Demand for Antimetabolite Drugs
According to Precision Business Insights (PBI), the latest report, the cytotoxic drugs market is expected to be valued at USD 15,927.2 million in 2022 and is poised to grow at a significant CAGR of 2.2% over 2022-2028. The primary drivers of the expansion of the global cytotoxic drugs market include the increasing prevalence of cancer diseases, the increasing use and approval of cytotoxic drugs, and the increasing consumption of alcohol…
Global Antithrombotic Drugs Market | Global Antithrombotic Drugs Industry | Glob …
Antithrombotic drugs are special drugs that help to prevent the formation of thrombus or clot. These drugs are used to reduce the formation of blood clots by reducing the capability of body to form a blood clot. Antithrombotic drugs act by preventing the production of vitamin K in the liver. Anticoagulant, antiplatelet, and thrombolytic agents are different types of antithrombotic agents that act by different clotting processes. Arterial & venous…
Global HIV Drugs Market | Global HIV Drugs Industry | Global HIV Drugs Market Re …
Human immunodeficiency Virus (HIV) could be a chronic and severe sickness which might be transferred from one person to a different through blood-to-blood and sexual contact. it's a deadly disease that attacks immune cells called CD-4 cells, creating body vulnerable to infections and alternative diseases. Over the years, the rising prevalence of HIV sickness worldwide has completely influenced the demand for HIV medicine. HIV medicine facilitate in preventing the multiplication…
Hepatitis Drugs Market by Therapeutics, Diagnostics, Patient, Drugs Policy
The global hepatitis drugs market is growing due to increasing incidences of hepatitis and increasing support from government organizations. In addition, the growing geriatric population, and increasing R&D investments on hepatitis research and drug discovery are also driving the growth of the global hepatitis drugs market.
Access Detailed Report Summary: https://www.psmarketresearch.com/market-analysis/hepatitis-drugs-market
Among the various types, the hepatitis C segment is expected to be the largest segment, and expected to witness the fastest…
Epilepsy Drugs Market by Country, Drugs, Company & Forecast
For More Information:
https://renub-research.blogspot.com/2019/04/the-factors-that-are-driving-global.html
Epilepsy is a chronic disease in which patient’s brain activities become abnormal due to seizures. Seizure is an unexpected rush of electrical activity in the brain. Seizure is categorized by two types - generalized seizures and focal or partial seizures. Generalized seizures affect the whole brain whereas focal or partial seizures affect just one part of the brain. Global epilepsy drugs market is expected to cross US$…
